Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Clinical trial NCT00940602 · COMPLETED
Trial details
- NCT number
- NCT00940602
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-22
- Primary completion
- 2018-02-27
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.